NDA 010349 · Hikma
Sparine
Promazine Hydrochloride · Injection
NovelDiscontinuedLast checked: Nov 20, 2026Latest source record: Apr 13, 1956 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1956
Apr 13, 1956
Approved uses
1
Original approval plus efficacy supplements
Registered trials
0
0 Phase 3, 0 recruiting
FAERS reports
0
0 serious, 0 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Apr 13, 1956 Original approval · Type 1 - New Molecular Entity
2 products under this application
- SPARINE · PROMAZINE HYDROCHLORIDE 50MG/ML · INJECTABLE, INJECTION · Discontinued
- SPARINE · PROMAZINE HYDROCHLORIDE 25MG/ML · INJECTABLE, INJECTION · Discontinued
Clinical trials
Interventional ClinicalTrials.gov studies with "Promazine" as an intervention, any sponsor and status, largest first.
No registered drug trials name this ingredient.
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
No FAERS reports name this application.
FAERS reports by year
By the date FDA received the report.
No reports.
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Comparative efficacy and safety of pharmacotherapies for alcohol withdrawal: a systematic review and network meta-analysis.
Bahji A, Bach P, Danilewitz M, et al. · Addiction 2022 · Systematic Review, Network Meta-Analysis
- Phenothiazine analgesia--fact or fantasy?
McGee JL, Alexander MR · Am J Hosp Pharm 1979 · Clinical Trial, Controlled Clinical Trial
- Acepromazine pharmacokinetics: a forensic perspective.
Schneiders FI, Noble GK, Boston RC, et al. · Vet J 2012 · Clinical Trial, Research Support, Non-U.S. Gov't
- Intraperitoneal fluid infusion in children with gastroenteritis.
Ransome-Kuti O, Elebute O, Agusto-Odutola T, et al. · Br Med J 1969 · Clinical Trial, Controlled Clinical Trial
- Increased paroxysmal activity of partial seizures in man by apomorphine.
Del Zompo M, Tocco F, Marrosu F, et al. · Psychopharmacology (Berl) 1983 · Clinical Trial, Controlled Clinical Trial
- A "Light Meal" Three Hours Preoperatively Decreases the Incidence of Gastro-Esophageal Reflux in Dogs.
Savvas I, Raptopoulos D, Rallis T · J Am Anim Hosp Assoc 2016 · Randomized Controlled Trial
Sponsor: Hikma
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.